4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rigel Pharmaceuticals, Inc. (RIGL) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 172 employees. Its market capitalization is roughly $764 million. In the fiscal year ended 2025-12-31, RIGL reported $294M in revenue and $367M in net income.
Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
Interactive charts & full statements → Open the RIGL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $294M | $179M | $117M | $120M | — |
| Gross Profit | $275M | $161M | $110M | $118M | — |
| Operating Income (EBIT) | $126M | $24M | ($20M) | ($54M) | — |
| Net Income | $367M | $18M | ($25M) | ($59M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $59M | $70M | $70M | $102M | $53M |
| Gross Profit | $54M | $64M | $65M | $97M | $49M |
| Operating Income (EBIT) | $12M | $23M | $28M | $61M | $13M |
| Net Income | $9M | $268M | $28M | $60M | $11M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $514M | $164M | $117M | $134M | — |
| Total Liabilities | $122M | $161M | $146M | $148M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RIGL viewer.
About TickerBase · Data methodology & sources